Genesys BioLabs, a business unit of 20/20 Genesystems, Inc., is dedicated to offering the most accurate and well validated biomarker based tests to aide in the early detection of lung cancer. We are staffed by a team of Ph.D. and M.D. level scientists and a management group that collectively has more than 50 years of experience in the diagnostics industry. We also have a Medical Advisory Board made up of practicing physicians from diverse specialties including primary care, pulmonary, radiology and thoracic surgery.